COMMUNIQUÉS West-GlobeNewswire
-
Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)
23/09/2026 -
Change in Roche’s Board of Directors
23/09/2026 -
InnovAge Announces Pricing of Secondary Offering of Common Stock by Selling Stockholders
23/09/2026 -
Hyagen Medical Participates in PepMed 2026 to Discuss Regulatory Clarity in Stem Cell Therapy
22/09/2026 -
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
22/09/2026 -
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
22/09/2026 -
Voting Rights and Shares Capital of the Company
22/09/2026 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
22/09/2026 -
Biomea Fusion Announces Proposed Public Offering of Securities
22/09/2026 -
InnovAge Announces Launch of Proposed Secondary Offering of Common Stock by Selling Stockholders
22/09/2026 -
Acquisition of Own Shares
22/09/2026 -
IN8bio to Present at Sidoti Small-Cap Virtual Conference
22/09/2026 -
Sherry Cummings, CEO of Gryphon Healthcare, Named a 2026 Houston Business Journal Women Who Mean Business Honoree
22/09/2026 -
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier
22/09/2026 -
Ossium Health Hosts U.S. Representative Erin Houchin at Indianapolis Production Facility
22/09/2026 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2026
22/09/2026 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 38 - 2026
22/09/2026 -
Applied Biologics Announces Last Patient, Last Visit in CAMPX Randomized Controlled Trial of XWRAP®
22/09/2026 -
SK pharmteco et GEMMABio renforcent leur collaboration dans la fabrication de traitements pour les maladies rares après une étape clé de l’essai clinique consacré à l’amyotrophie spinale (SMA)
22/09/2026
Pages